10.01 Prostanoid-insensitive chimeric antigen receptor modified T cells mediate therapeutic efficacy in solid cancer models

• J Dorr,
• S Stock,
• S Kobold,
• S Michaelides,
• S Lesch,
• A Gottschlich,
• A Öner,
• D Briukhovetska,
• L Fertig,
• L Gregor,
• SB Lacher,
• L Majed,
• E Carlini,
• D Andreu Sanz,
• JP Böttcher

Affiliations

J Dorr

Department of Neurology, Helios-Klinikum, Berlin, Germany

S Stock

2Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany

S Kobold

3Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany

S Michaelides

1Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig Maximilian University (LMU) of Munich, München, Germany

S Lesch

1Division of Clinical Pharmacology, Munich, Germany

A Gottschlich

1Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig Maximilian University (LMU) of Munich, München, Germany

A Öner

1Division of Clinical Pharmacology, Munich, Germany

D Briukhovetska

1Klinikum der Universität München, Munich, Germany

L Fertig

1Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany

L Gregor

1Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig Maximilian University (LMU) of Munich, München, Germany

SB Lacher

2Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), München, Germany

L Majed

1Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig Maximilian University (LMU) of Munich, München, Germany

E Carlini

1Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig Maximilian University (LMU) of Munich, München, Germany

D Andreu Sanz

1Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig Maximilian University (LMU) of Munich, München, Germany

JP Böttcher

2Institute of Molecular Immunology, School of Medicine and Health, Technical University of Munich (TUM), München, Germany